Dr. Daniel A. Roque, M.D.
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- University of Miami, Lm Miller School of Medicine (2008)
- Years since graduation
- 18
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 140
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Medical school: University of Miami, Lm Miller School of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
NC license 2012-00403 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Unc Hospitals Chapel Hill, NC
Medical groups
- University of North Carolina at Chapel Hill (2,052 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 140
- Services billed
- 730
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 145 | 106 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 81 | 37 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 65 | 45 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | 61 | 36 |
| Established patient office or other outpatient visit, 30-39 minutes | 35 | 31 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 32 | 12 |
| New patient office or other outpatient visit, 60-74 minutes | 19 | 19 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Chapel Hill, NC | 130 |
| Primidone Other prescribers in Chapel Hill, NC | 72 |
| Amantadine (amantadine hcl) Other prescribers in Chapel Hill, NC | 34 |
| Clonazepam Other prescribers in Chapel Hill, NC | 33 |
| Baclofen Other prescribers in Chapel Hill, NC | 29 |
| Ingrezza (valbenazine tosylate) Other prescribers in Chapel Hill, NC | 24 |
| Carbidopa-Levodopa Er (carbidopa/levodopa) Other prescribers in Chapel Hill, NC | 22 |
| Gabapentin Other prescribers in Chapel Hill, NC | 20 |
| Propranolol Hcl Other prescribers in Chapel Hill, NC | 20 |
| Citalopram Hbr (citalopram hydrobromide) Other prescribers in Chapel Hill, NC | 19 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 2 payments worth $216 in total to this clinician.
| Insightec,inc | $125 |
|---|---|
| Boston Scientific Corporation | $90.54 |
| Food and Beverage | $216 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $23,293 in research payments for these studies, mostly to the institutions running them.
- Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor
AbbVie Inc. · Completed · NCT05216250 - Study to Evaluate SAGE-324 in Participants With Essential Tremors
Sage Therapeutics, LLC - M21-471 - Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor
AbbVie Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.